Johnson & Johnson ($JNJ) is fighting more than 1,500 legal claims that its antipsychotic Risperdal triggered breast development in boys, and the company has landed on the wrong side of a jury verdict in several of them so far.
The same thing happened Friday in a Philadelphia court. The difference, this time, is that the jury smacked J&J with a $70 million damages award–many times larger than previous awards in similar cases.
In the first of these cases to go to trial, a jury handed $2.5 million to the plaintiff, a teenager who had developed 46DD breasts after taking Risperdal. Another verdict, last November, included $1.75 million in damages.
First-to-trial “bellwether” cases are closely watched as indicators of a potential settlement–or lack of one. Because of its size, this latest verdict could increase the pressure on J&J to come to an agreement with the rest of the plaintiffs.
I knew one guy who had his breasts swell up on the stuff and then they didn’t shrink when he changed to Geodon. Last I heard he was trying to get the government to pay for surgery for breast reduction. There’s something seriously wrong with a med that leaves a person in that state.
“In the first of these cases to go to trial, a jury handed $2.5 million to
the plaintiff, a teenager who had developed 46DD breasts after taking
Risperdal”
I’d handle having boobies for a while for a cool 2.5 million.
AND… I would demand to use the ladies’ washroom (boobs, right? RIGHT?) and demand another 2.5M if anyone says no. If life gives you melons, er, lemons…
Risperdal caused me to have breasts and i only took it for a year. I met one guy on it who had breasts from it but refused to admit he had any and thought it was because he was fat
